דלג לתוכן הראשי
Muscles

Creatine and Strength Training After 60: How Much Does It Really Add?

New headlines claim that creatine combined with strength training increases strength and muscle mass in older adults. Meta-analyses from 2017 to 2026 paint a more precise picture: a small to moderate gain in strength, an added kilogram to a kilogram and a half of lean tissue in some analyses, and real uncertainty about everyday function and frail populations. Here is what the data actually show.

⏱️19 Reading minutes ✍️Nir Nagar 👁️2 Views

Some products are born in the gym and end up in the clinic. Creatine is the classic example: a substance known mainly to young weightlifters that, over the years, became one of the most studied supplements in the world, including among people aged 60 and over. Every few months a new headline appears announcing that it "increases strength and muscle mass in older adults," and this time it came from the news site Bioengineer.org.

But when you lift the lid on the headline, a more interesting story emerges. The question is no longer whether creatine "works." The question is how much exactly it adds beyond the training itself, on which outcome (strength? mass? the ability to get up from a chair?), and for which kind of older adults. Different meta-analyses, published between 2017 and 2026, do not agree with each other on every point. Those differences are exactly what is worth understanding before spending money on a supplement.

So as not to rely on a single analysis, here we will go over four key meta-analyses on the topic, from 2017 through a new 2026 meta-analysis that reaches a more cautious conclusion.

What is creatine?

Creatine is a substance the body produces on its own and that is also found in food, mainly in meat and fish. The most common and most studied supplement is creatine monohydrate. To understand what it does, it helps to go over a few basic facts:

  • A fast energy reserve in muscle: inside muscle cells, creatine binds to phosphate and forms phosphocreatine. This is a reserve that helps rapidly regenerate ATP, the cell's energy currency, during short, intense effort.
  • A supplement, not a drug: taking creatine raises creatine and phosphocreatine stores inside the muscle, according to the International Society of Sports Nutrition position stand cited in the 2026 meta-analysis.
  • Only together with training: according to reviews cited in that meta-analysis, the effect of creatine alone on strength and muscle mass in older adults is inconsistent, and the benefit is more pronounced when it is taken together with resistance training.
  • A different question than usual: what is being tested here is the add-on. That is, not "training versus nothing," but "training with creatine versus training with placebo."

The last point is especially important. Strength training alone already builds muscle and strength even at an older age, as we explained in other articles on the site. The question is whether creatine adds on top of that baseline, and by how much.

How is creatine supposed to help the aging muscle?

The accepted mechanism is training quality. If there is more phosphocreatine in the muscle, you can perform an extra repetition, an extra set, or hold a slightly higher load. According to the International Society of Sports Nutrition position stand, as cited in the 2026 meta-analysis, this may improve training volume, quality and recovery. Higher-quality training over weeks and months leads, in theory, to greater adaptations in strength and mass.

In older age there is a particular reason to think this mechanism is relevant. The 2026 meta-analysis notes that in older age there are changes in muscle energy metabolism that may limit the response to the training stimulus. If this assumption is correct, a small amount of creatine might "compensate" for part of the gap. It is important to stress: this is a reasonable hypothesis, not a mechanism proven by direct measurements. The authors of the 2017 meta-analysis, detailed below, wrote explicitly that the mechanisms through which creatine exerts its effects have not yet been widely examined.

Other mechanisms are mentioned in the literature: effects on the amount of water inside muscle cells, on cellular signaling, and on muscle stem cells. These are research directions, not established mechanisms. That is why it is important to stay humble when explaining "why" it works. What the meta-analyses can say is only what was measured, and not always why.

There is also a methodological point that is important to know already here. When we talk about "muscle mass" in these trials, what is usually measured is lean tissue mass. This is a measurement that includes muscle, but also water and other non-fat tissues. So an increase in lean mass is not necessarily an increase in active muscle fibers. We will return to this in the critical section.

The current evidence

Before the details, a brief explanation of the type of evidence. All four studies below are meta-analyses: analyses that pool the results of relatively small randomized controlled trials (RCTs). This is a higher level of evidence than a single trial, but it depends on the quality of the trials within it. To compare the results it helps to know two measures: the mean difference (for example, kilograms) and the standardized effect size (SMD or g), a unitless measure in which values around 0.2 are considered small, around 0.5 moderate, and around 0.8 large.

Study 1: Chilibeck and colleagues, Open Access Journal of Sports Medicine, 2017

This is the meta-analysis that largely set the narrative. It pooled 22 randomized trials with 721 participants aged 57 to 70 on average, men and women, as summarized in a later review. The results:

  • Lean tissue mass: a greater increase in the creatine group, with a mean difference of 1.37 kg (95% confidence interval: 0.97 to 1.76).
  • Chest press strength: an effect size of 0.35 (confidence interval: 0.16 to 0.53). This is a small to moderate effect.
  • Leg press strength: an effect size of 0.24, that is, smaller.

The researchers' conclusion: creatine during resistance training in older adults increases lean tissue mass and strength in both the upper and lower body. Note: the difference of about 1.4 kg is an average across trials of different lengths, and it was measured in lean tissue, not in pure muscle.

Study 2: Forbes and colleagues, Nutrients, 2021

This meta-analysis, with the participation of researchers from the group that studies creatine in older age, asked a practical question: does the way it is taken matter? It included people aged 50 and over (lean tissue mass data: 509 participants, strength data: 426), and divided the trials by dose (low, up to 5 g per day, versus high, above 5 g), by the presence of a loading phase (20 g or more per day for 5 to 7 days), and by intake on training days only.

  • The pooled result: creatine plus training increased lean tissue mass by about 1.2 kg more than placebo plus training, and also improved chest press and leg press strength.
  • Dose: the authors conclude that creatine improves mass and strength regardless of the dosing strategy.
  • Intake on training days only: this also improved lean tissue mass and strength compared with placebo.

This is a conclusion with practical implications: there is no evidence that an intensive loading phase is required, and small doses appear to be sufficient. However, these are comparisons between different trials and not a direct comparison within the same trial.

Study 3: A meta-analysis in the European Review of Aging and Physical Activity, 2025

The researchers searched eight databases, and their screening was strict: 8 randomized trials with 482 older participants who trained 2 to 3 times per week for 8 to 104 weeks, with creatine or placebo. They examined lean tissue mass, chest press and leg press. The work was pre-registered in PROSPERO.

  • Lean tissue mass: a statistically significant but small increase (SMD = 0.27, 95% confidence interval: 0.02 to 0.53). The lower bound of the interval is very close to zero.
  • Lower-body strength: an improvement on the borderline of significance (SMD = 0.29, 95% confidence interval: 0.00 to 0.57, p = 0.05). The lower bound of the interval is zero.
  • Upper-body strength: according to the authors, no clinically meaningful effect in the overall analysis.
  • By intervention duration: in trials of up to 32 weeks (5 trials), larger improvements were found: an SMD of 0.45 in upper-body strength (confidence interval: 0.14 to 0.77) and an SMD of 0.57 in lean tissue mass (confidence interval: 0.19 to 0.96). In trials of 52 weeks or more, no statistically significant improvement was found.

Cautious summary: according to this meta-analysis, creatine adds lower-limb strength and lean mass, but only a small gain. The intervention-duration finding should be read with caution, because it is based on a subgroup split with few trials in each. It may be that the difference stems from other differences between the short and long trials and not from time itself. Indeed, the next meta-analysis did not find that intervention duration explains the variability in results.

Study 4: Yao, Yang and Gao, Frontiers in Nutrition, August 25, 2026

This is the most recent and most stringent meta-analysis. It focused solely on people aged 60 and over (and not 50, as in earlier analyses), was pre-registered in PROSPERO, and used modern appraisal tools: a three-level statistical model that accounts for the same trial reporting several related outcomes, a check for publication bias, and rating of the certainty of evidence using the GRADE method.

The data: 11 randomized trials published between 1998 and 2026, from Canada (4), Brazil (4), and Spain, France and Iran (one each). A pooled mean age of 67.4 years (standard deviation 6.5). Most participants were healthy, sedentary or community-dwelling, and only one trial included older adults at higher health risk. In the trials detailed in the study, many groups were small: between 8 and 16 participants per group. The results:

  • Muscle strength: a significant but small improvement (g = 0.31, 95% confidence interval: 0.18 to 0.45), with moderate certainty by GRADE.
  • Muscle mass: g = 0.35, but the confidence interval is wide and crosses zero (minus 0.09 to 0.78). Not statistically significant, with low certainty.
  • Physical function (such as rising from a chair and walking): g = 0.47, also not significant (confidence interval: minus 0.08 to 1.03; p = 0.086), with very low certainty.
  • Explanatory factors: dose, loading phase, intervention duration, training frequency, intensity, sex and measurement site were not identified as stably explaining the variability between trials.

The authors' conclusion: in generally healthy older adults, creatine may serve as a complementary supplement for a modest improvement in strength, while its contribution to mass and function remains uncertain. They added a warning: no inference should be drawn from this about frail, sarcopenic older adults or those with functional limitation.

Note a subtle point. The point estimate for mass (0.35) is similar to the estimate for strength (0.31), and even larger. What distinguishes them is the width of the confidence interval. That is, it would be wrong to say that "creatine does not build muscle." It is more accurate to say that this analysis could not determine with confidence whether there is an effect, because the data are few and scattered. Absence of proof is not proof of absence.

How do we reconcile the analyses?

On the surface there is a contradiction: earlier analyses found a significant gain in mass, and the 2026 analysis did not. Several explanations are plausible, none of them certain:

  • Population definition: earlier analyses also included people aged 50 and over, and the latest analysis only those 60 and over. The narrowing reduces the number of trials and the statistical power.
  • Statistical method: the three-level model better accounts for dependence between outcomes, and may yield wider confidence intervals.
  • Trial quality: some of the trials are old, small and less well documented.

What they all share: the direction of the result is consistent, in favor of creatine, and the effect size is small to moderate. What differs: the statistical confidence in mass.

The wider picture: beyond muscle

Research on creatine in older age also extends beyond muscle.

A 2025 narrative review on the muscle-brain axis examines whether creatine and physical activity also affect cognition. This is a young field in which the evidence is still far more preliminary than the evidence for muscle, so we will not go into it here.

Should you start taking creatine?

This is the question this article is meant to answer, and the answer is honest: it depends on who you are and what you expect. Here are caveats worth knowing:

  • The effect is modest. An effect size of 0.3 is small. Put simply: if you compare trainees with creatine to trainees without, there is large overlap between the groups. The creatine group's average is slightly higher, but not every person will feel a difference.
  • Training is what matters most. All the trials included supervised resistance training, usually 2 to 3 times per week. Creatine is not a substitute for training, and according to cited reviews, its benefit without training is inconsistent.
  • "Lean mass" does not equal "muscle." Part of the increase may come from water inside cells or from other tissues. A gain of a kilogram to a kilogram and a half is an interesting finding, but it does not guarantee the same gain in functional muscles.
  • Everyday function has not been proven. In the latest meta-analysis, the ability to rise from a chair, walk and get around (physical function) did not improve significantly, and the certainty is very low. The measure that matters for real life is precisely the measure that is least well established.
  • Frail populations have not been studied enough. Most participants were relatively healthy and active. The authors themselves warn against generalizing to frail people and those with sarcopenia, precisely the people we would most like to help.
  • Small trials and gaps between studies. With 8 to 16 participants per group, a single trial is exposed to chance. Even a meta-analysis cannot fix weak trials.
  • The intervention-duration finding is a hint, not a law. A larger improvement in trials of up to 32 weeks does not mean creatine "stops working" after that. It is based on few trials, and another meta-analysis did not find it.
  • Long-term safety data. Reviews on the topic note that creatine monohydrate is considered safe in older adults, but this is mainly based on short, small trials. Anyone living with kidney disease, or taking medications regularly, should consult a doctor before starting. Mild side effects, such as slight weight gain and gastrointestinal discomfort, are reported in the general literature on creatine.
  • Cost and product uncertainty. Dietary supplements are not tested the way drugs are. It is advisable to choose clean, well-known creatine monohydrate, without blends containing other substances.

Bottom line: this is not a miracle drug, but a small, relatively safe add-on, with reasonable evidence for a modest improvement in strength. Someone who already trains consistently, is healthy, and wants to try it can consider it in consultation with a doctor. Someone who does not train should not buy the supplement instead of starting to train.

What to take from the research

  1. First of all, training. Without a regular resistance training program, 2 to 3 times per week, there is no reason to expect benefit from creatine. All the trials included in the analyses were conducted together with supervised, progressive training.
  2. If you decide to try: the trials used doses such as 5 g per day, or about 0.07 to 0.1 g per kg of body weight per day (some with a 5-day loading phase at the start, and some only on training days). The analyses did not find that loading or a higher dose improves the result, so there is no reason to push high doses. The dose that suits you is a matter for personal consultation with a doctor or dietitian.
  3. Consult a doctor before starting, especially if you have kidney disease, diabetes, or take regular medications. Do not start a supplement because of a headline.
  4. Set realistic expectations and measure properly. Do not judge by body weight alone, because creatine may raise weight slightly. Track your strength: how much weight you lift and how many repetitions you perform. This is the measure in which the most consistent benefit was found.
  5. Do not forget the rest of the foundation. Adequate protein, sleep and general physical activity affect muscle more than any supplement, and their evidence is much stronger.

The broader perspective

The creatine story is a good example of how science really advances: not in sensational leaps, but in the slow clarification of effect size. Trials in older adults were already being conducted in the 1990s (the earliest trial included in the 2026 analysis was published in 1998), and decades later we are still refining the answer. What began as "a supplement that helps build muscle" has become "a supplement that adds a small boost to training, mainly in strength, at least in healthy people." It is a less exciting headline, but a much more truthful one.

The broader principle worth taking to the entire longevity field: targeted supplements improve what habits have already built, and do not replace them. They add a few percentage points on top of a strong foundation, and the foundation is training. Whoever understands this saves money, and whoever does not is left with a full jar and the same strength.

Creatine may add a little, but it is training that lifts you out of the chair.

References:
The impact of creatine supplementation associated with resistance training on muscular strength and lean tissue mass in the aged: a systematic review and meta-analysis, European Review of Aging and Physical Activity, 2025
Effects of resistance training combined with creatine supplementation on muscle strength, physical function, and muscle mass in older adults: a systematic review and three-level meta-analysis, Frontiers in Nutrition, 2026
Bioengineer.org: Creatine With Resistance Training Boosts Older Adult Strength and Muscle Mass

ניר נגר

Nir Nagar

Nir Nagar, founder and editor of Reverse Aging and a biohacker with over 20 years of hands-on experience in longevity research, supplements, and health optimization. He researches every topic in depth before publishing, honestly grades the strength of the evidence, and links to the original studies in every article.

Full profile ↗

Sources and citations

💬 Comments (0)

To respond, you need an account. Write your response and click publish, and you will be taken to a quick registration. The response will be saved and published after approval.

Be the first to comment on the article.

Did you enjoy the site? Tell your friends 🙌 Didn't enjoy it? Tell us and we'll improve 💬

💬 Tell us